Matthew Hulett: Thanks, Christine. No, you answered — you actually added a couple of elements that I was going to add, Anthony. I would say that, we don’t have a lot of shots on goal with our customers today, meaning primarily, our customer engagement is over a year around prescription refills. And so that gives ample opportunity for customers to not engage with us and not have reengagement and likely either go to another retailer or actually forget that they’re on some type of program with us. And so we’re looking to get more engagement with those customers through AutoShip, but also through selling more products. We think selling more products in AutoShip is kind of a one two punch to answer that question because there is more competition in the market, but also our customers want more products from us.
And so we think the advent of those two things will really help bolster and stabilize the returning base over time. And then as I’ve mentioned, more speculative investments that we’ve made on pet telemedicine, I think, are going to be really interesting to see how, over the long term, the regulatory environment changes, but also how customers view PetMeds as not just a place to get your meds, but it’s also a place to get all your other services that you’d expect to get. And our customers are very much aligned with how they think about their vet, and so which is why we really focus on pet telemedicine and connecting with that through our vet live service. So over time, we think differentiation through services is going to be another ability for us to lower churn and provide a more meaningful experience for our customers.
Anthony Lebiedzinski: Got it. Yeah. Thanks for that. And then your advertising spending was up 7%. Just wondering, are you seeing any changes in ad rates, given kind of where the economy is right now? I just wanted to get your thoughts on that.
Matthew Hulett: Yeah. I’ll take that one, Christine, Anthony. Good question. Yeah. When I say relatively flat, obviously, there was a little bit of an increase. No, largely, the fluctuations that we’ve seen are how we get incented from our supplier partners, which adds some variance. So we feel like overall, from what we see inside our marketing spend that we’ve been relatively flat. There can be some variances based on the amount of discounts that flow through the P&L from our supplier partners, but overall, when we look at the industry, whether it’s CPCs or CPMs, we’re not seeing a lot of fluctuation in price right now. That can change and it has changed significantly quarter-over-quarter base usually on the macro environment, but it has somewhat stabilized in terms of our customer acquisition costs, and we’re not super concerned about that.
Anthony Lebiedzinski: Got it. Okay. Well, thank you and best of luck.
Matthew Hulett: Thanks, Anthony for your questions.
Operator: There are no further questions in the queue. I’d like to hand the call back to management for closing remarks.
Matthew Hulett: Thank you for joining our call today. I’m confident that the future we envision for PetMeds along with the foundation that we’ve been laying will meet the market opportunity in unique and innovative ways and will lead to improved operating results and increase shareholder value. PetMed’s brand expertise and reputation are unparalleled. We have greatly accelerated our operating roadmap, and we look forward to sharing our progress in positively changing the lives of our pet parents and pets. Thank you for your continued support.
Operator: Ladies and gentlemen, this does conclude today’s teleconference. Thank you for your participation. You may disconnect your lines at this time, and have a wonderful day.
